Lipids and lipoproteins represent main risk factors for the development and
the progress of atherosclerotic and cardiovascular diseases. Disorders in
lipoprotein metabolism may result in diabetes mellitus, acute pancreatitis,
and in the early occurrence of atherosclerotic alterations. The plasma con
centration of high density lipoproteins (HDL) is inverse correlated with th
e risk of cardiovascular diseases as shown in epidemiologic studies. HDL pl
ay an important role in the reverse cholesterol transport. Free cholesterol
from peripheral cells can be assembled in HDL particles, transformed to ch
olesterol esters, transported to the liver, and secreted via the bile as bi
le acids. The metabolism of HDL is not known in detail. Numerous factors we
re identified to influence the metabolism of HDL. Particularly the identifi
cation of the cholesterol efflux regulating protein adduced new insights in
HDL metabolism. A detailed description of HDL metabolism is necessary for
the evaluation of new therapeutic strategies for the regulation of the seru
m concentration of this important lipoprotein. Here we describe the known i
nfluencing factors for a better understanding of HDL metabolism.